Literature DB >> 29066406

An ethnopharmacological survey of medicinal plants traditionally used for cancer treatment in the Ashanti region, Ghana.

Christian Agyare1, Verena Spiegler2, Alex Asase3, Michael Scholz2, Georg Hempel4, Andreas Hensel5.   

Abstract

AIMS: Cancer represents a major health burden and drain on healthcare resources in the world. The majority of the people of Africa still patronize traditional medicine for their health needs, including various forms of cancer. The aim of the following study is the identification of medicinal plants used for cancer treatment by the traditional healers in the Ashanti area of Ghana and to cross-reference the identified plant species with published scientific literature.
METHODOLOGY: Validated questionnaires were administered to 85 traditional healers in 10 communities within Ashanti region. For cross-validation, also 7 healers located outside Ashanti region were investigated to evaluate regional differences. Interviews and structured conversations were used to administer the questionnaires. Selected herbal material dominantly used by the healers was collected and identified.
RESULTS: The ethnopharmacological survey revealed 151 plant species used for cancer treatment. Identified species were classified into different groups according to their frequency of use, resulting in the "top-22" plants. Interestingly group I (very frequent use) contained 5 plant species (Khaya senegalensis, Triplochiton scleroxylon, Azadirachta indica, Entandrophragma angolense, Terminalia superba), three of which belong to the plant family Meliaceae, phytochemically mainly characterized by the presence of limonoids. Cross-referencing of all plants identified by current scientific literature revealed species which have not been documented for cancer therapy until now. Special interest was laid on use of plants for cancer treatment of children.
CONCLUSION: A variety of traditionally used anti-cancer plants from Ghana have been identified and the widespread use within ethnotraditional medicine is obvious. Further in vitro and clinical studies will be performed in the near future to rationalize the phytochemical and functional scientific background of the respective extracts for cancer treatment.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Azadirachta indica; Cancer; Entandrophragma angolense; Ghana; Khaya senegalensis; Terminalia superba; Triplochiton scleroxylon

Mesh:

Year:  2017        PMID: 29066406     DOI: 10.1016/j.jep.2017.10.019

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Incidence and mortality of cancer in the Volta Region of Ghana.

Authors:  Samuel M Adadey; Sylvester Languon; Richmond Ayee; Darius Nk Quansah; Osbourne Quaye
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-04

Review 2.  Selected Species of the Cucurbitaceae Family Used in Mexico for the Treatment of Diabetes Mellitus.

Authors:  Maira Huerta-Reyes; Rosario Tavera-Hernández; J Javier Alvarado-Sansininea; Manuel Jiménez-Estrada
Journal:  Molecules       Date:  2022-05-26       Impact factor: 4.927

3.  Anthelmintic A-Type Procyanidins and Further Characterization of the Phenolic Composition of a Root Extract from Paullinia pinnata.

Authors:  Verena Spiegler
Journal:  Molecules       Date:  2020-05-13       Impact factor: 4.411

4.  The effects of the ethanol extract of Cordia myxa leaves on the cognitive function in mice.

Authors:  Gülsen Kendir; Ho Jung Bae; Jihyun Kim; Yongwoo Jeong; Hyo Jeoung Bae; Keontae Park; Xingquan Yang; Young-Jin Cho; Ji-Young Kim; Seo Yun Jung; Ayşegül Köroğlu; Dae Sik Jang; Jong Hoon Ryu
Journal:  BMC Complement Med Ther       Date:  2022-08-10

5.  Acetic Acid-Induced Ulcerative Colitis in Sprague Dawley Rats Is Suppressed by Hydroethanolic Extract of Cordia vignei Leaves through Reduced Serum Levels of TNF-α and IL-6.

Authors:  George Owusu; David D Obiri; George K Ainooson; Newman Osafo; Aaron O Antwi; Babatunde M Duduyemi; Charles Ansah
Journal:  Int J Chronic Dis       Date:  2020-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.